Chinese medicinal capsule for treating malignant lymphoma

A technology of malignant lymphoma and traditional Chinese medicine capsules, which is applied in the direction of capsule delivery, antineoplastic drugs, drug combinations, etc., can solve the problems of decline, side effects, immune function, etc., and achieve the effect of high clinical benefit rate

Inactive Publication Date: 2009-11-25
李宗宪
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, Western medicine treats malignant lymphoma, including radiotherapy, chemotherapy, biological therapy and other treatment options. Although good curative effect has been achieved, for a large number of patients, it can cause serious side effects and decline in immune function

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] This example is prepared by using the following raw materials in weight: Pinellia 60 grams, Tangerine Peel 60 grams, Cat’s Claw 120 grams, Prunella vulgaris 120 grams, White Mustard Seed 60 grams, Tianlong 30 grams, Polyporus 120 grams, Fritillaria 40 grams , 200 grams of oysters, wash and dry the above-mentioned raw materials and carry out superfine pulverization, the fineness reaches 400 mesh, make powder and inject capsules, the powder charge of each capsule is 1 gram, take 5 capsules each time, Take it twice a day, morning and evening. One month is a course of treatment, and two courses of treatment are used to evaluate the curative effect.

[0011] The present invention selects pinellia, tangerine peel, cat's claw, prunella vulgaris, white mustard seed, tianlong, polyporus, fritillaria and oyster for combination, and after combination, the efficacy of each drug produces synergistic effect, thereby effectively treating malignant lymphoma. Among them Pinellia is pun...

Embodiment 2

[0013] In this example, the following raw materials are used: Pinellia 80 grams, Tangerine Peel 40 grams, Cat’s Claw 100 grams, Prunella vulgaris 100 grams, White Mustard Seed 80 grams, Tianlong 30 grams, Polyporus 150 grams, Fritillaria 50 grams , 250 grams of oysters, wash and dry the above-mentioned raw materials and carry out superfine pulverization, the fineness reaches 400 meshes, make powder and inject capsules, the powder charge of each capsule is 1 gram, take 5 capsules each time, Take it twice a day, morning and evening. One month is a course of treatment, and two courses of treatment are used to evaluate the curative effect.

[0014] Each raw material of the present invention can also be realized by the embodiment that the ratio listed in the following table is mixed. Its processing is identical with embodiment 1. (unit: gram)

[0015] implement

example

pinellia

Chenpi

cat paw

Grass

Prunella

Grass

white must...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the field of medicament formulation, in particular to a Chinese medicinal capsule for treating malignant lymphoma. Pinellia tuber, tangerine peel, radix ranunculi ternati, self-heal, mustard seed, wall lizard, polyporus umbellatus, fritillaria and oyster are used as raw materials; and the raw materials are cleaned, dried and ultramicro-crushed to reach the fineness of 400 meshes, the crushed raw materials are prepared into powder, and the powder is filled into capsules. The Chinese medicinal capsule is characterized in that the following raw materials by weight portion: 3 to 9 portions of the pinellia tuber, 3 to 9 portions of the tangerine peel, 9 to 15 portions of the radix ranunculi ternati, 9 to 15 portions of the self-heal, 3 to 9 portions of the mustard seed, 1.5 to 4.5 portions of the wall lizard, 6 to 18 portions of the polyporus umbellatus, 3 to 6 portions of the fritillaria and 15 to 30 portions of the oyster. The Chinese medicinal capsule has the remarkable efficacies of softening hardness and dissipating binds, reducing phlegm and resolving toxin, soothing liver and strengthening stomach, and supporting right qi, has no obvious toxic and side effect after a patient takes the capsule, is applicable to the treatment of the malignant lymphoma, and has high clinical yield.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a Chinese medicine capsule for treating malignant lymphoma. Background technique [0002] As we all know, malignant tumors are increasing all over the world, and the incidence of malignant tumors in my country is also increasing year by year. Malignant lymphoma accounts for 4.1% of the total incidence of malignant tumors. It is a malignant tumor derived from lymphoid tissue and closely related to immunity. It mainly occurs in lymph nodes, and can also occur in extralymphatic and non-lymphoid tissues. Divided into Hodgkin's disease and non-Hodgkin's lymphoma, the main manifestations are painless progressive lymphadenopathy, fever, night sweats, fatigue and other symptoms. Depending on the location of the disease and the different pathological types, there may be other corresponding clinical manifestations. Pathological diagnosis is the gold standard for the diagnosis of m...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/8966A61K9/48A61P35/00A61K35/64A61K35/56A61K35/583A61K35/618A61K35/648
Inventor 李宗宪刘秀萍吕清华
Owner 李宗宪
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products